Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women.

Recent epidemiologic studies have suggested that genetic polymorphisms in the cytochrome P-450 1A1 gene (CYP1A1) may affect the relation between environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer risk. The authors report results from a case-control study evaluating the potential effect of gene-environment interaction between CYP1A1 and serum PCB levels on breast cancer risk among Caucasian women in Connecticut. The study included 374 case women with histologically confirmed breast cancer and 406 noncancerous controls with information on both serum PCB level and CYP1A1 genotype (1999-2002). Compared with women who had the homozygous wild-type CYP1A1 m2 genotype, significantly increased risks of breast cancer were found for women with the CYP1A1 m2 variant genotype (odds ratio (OR) = 2.1, 95% confidence interval (CI): 1.1, 3.9), especially postmenopausal women (OR = 2.4, 95% CI: 1.1, 5.0). Risks associated with the CYP1A1 m2 variant genotype were highest for all women (OR = 3.6, 95% CI: 1.5, 8.2) and postmenopausal women (OR = 4.3, 95% CI: 1.6, 12.0) with higher serum PCB levels (611-2,600 ng/g). The CYP1A1 m1 and m4 genotypes were not associated with breast cancer risk independently or in combination with PCB exposure. In summary, the CYP1A1 m2 genetic polymorphism was associated with increased risk of female breast cancer and may modify the relation between PCB exposure and breast cancer risk.

[1]  D. Hunter,et al.  Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  P. Ayotte,et al.  Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. , 2002, American journal of epidemiology.

[3]  T. Holford,et al.  1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. , 2001, Journal of the National Cancer Institute.

[4]  I. Roots,et al.  Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. , 2001, Carcinogenesis.

[5]  A. Andersen,et al.  Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  P. Boyle,et al.  Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk. , 2000, International journal of epidemiology.

[7]  R. Millikan,et al.  Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  P. Boyle,et al.  Breast cancer risk associated with congeners of polychlorinated biphenyls. , 2000, American journal of epidemiology.

[9]  N. Dubin,et al.  Risk of breast cancer and organochlorine exposure. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  P. Boyle,et al.  Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  J. Brock,et al.  Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  N. Rothman,et al.  Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA) , 1999, Cancer Causes & Control.

[13]  P. Grandjean,et al.  Organochlorine exposure and risk of breast cancer , 1998, The Lancet.

[14]  S D Stellman,et al.  Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  J. Freudenheim,et al.  Environmental organochlorine exposure and postmenopausal breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  W. Willett,et al.  Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. , 1998, Cancer research.

[17]  T. Keefe,et al.  Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. , 1997, Journal of toxicology and environmental health.

[18]  J. Manson,et al.  Plasma organochlorine levels and the risk of breast cancer. , 1997, The New England journal of medicine.

[19]  F. Guengerich,et al.  Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. , 1996, Cancer research.

[20]  E. Taioli,et al.  A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. , 1995, Cancer research.

[21]  J. Freudenheim,et al.  Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.

[22]  K. Buetow,et al.  Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  R. Hiatt,et al.  Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. , 1994, Journal of the National Cancer Institute.

[24]  R. Verreault,et al.  High organochlorine body burden in women with estrogen receptor-positive breast cancer. , 1994, Journal of the National Cancer Institute.

[25]  E. Taioli,et al.  Relationship between genotype and function of the human CYP1A1 gene. , 1993, Journal of toxicology and environmental health.

[26]  N Dubin,et al.  Blood levels of organochlorine residues and risk of breast cancer. , 1993, Journal of the National Cancer Institute.

[27]  J. Godbold,et al.  Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. , 1992, Archives of environmental health.

[28]  M. Macleod,et al.  Differences in the rate of DNA adduct removal and the efficiency of mutagenesis for two benzo[a]pyrene diol epoxides in CHO cells. , 1991, Mutation research.

[29]  D. Nebert.  Role of genetics and drug metabolism in human cancer risk. , 1991, Mutation research.

[30]  J. Selkirk,et al.  Benzo(a)pyrene:DNA adduct formation in normal human mammary epithelial cell cultures and the human mammary carcinoma T47D cell line. , 1986, Cancer research.

[31]  J. Freudenheim,et al.  Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  B. Bush,et al.  Induction of hepatic cytochromes P450 in dogs exposed to a chronic low dose of polychlorinated biphenyls. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  N. Roodi,et al.  Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. , 1998, Cancer research.